| 1 |
31647557 | Kinetic and solvent isotope effects in oxidation of halogen derivatives of tyramine catalyzed by monoamine oxidase A. | 2020 Jan 1 |
1 |
| 2 |
32942081 | A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer's disease agents: A review. | 2020 Nov 15 |
1 |
| 3 |
31736764 | Highly Variable Pharmacokinetics of Tyramine in Humans and Polymorphisms in OCT1, CYP2D6, and MAO-A. | 2019 |
5 |
| 4 |
30003648 | Monoamine oxidase-A is a novel driver of stress-induced premature senescence through inhibition of parkin-mediated mitophagy. | 2018 Oct |
1 |
| 5 |
30039351 | Mechanisms of the antilipolytic response of human adipocytes to tyramine, a trace amine present in food. | 2018 Nov |
1 |
| 6 |
28682929 | Determination of Monoamine Oxidase A and B Activity in Long-Term Treated Patients With Parkinson Disease. | 2017 Sep/Oct |
1 |
| 7 |
21628600 | The monoamine oxidase type B inhibitor rasagiline in the treatment of Parkinson disease: is tyramine a challenge? | 2012 May |
2 |
| 8 |
21224199 | Selegiline and rasagiline: twins or distant cousins? | 2011 Jan |
1 |
| 9 |
22078410 | Time-dependent slowly-reversible inhibition of monoamine oxidase A by N-substituted 1,2,3,6-tetrahydropyridines. | 2011 Dec 15 |
1 |
| 10 |
17284087 | Selegiline transdermal system: in the treatment of major depressive disorder. | 2007 |
1 |
| 11 |
17401530 | Factors affecting the relative importance of amine oxidases and monooxygenases in the in vivo metabolism of xenobiotic amines in humans. | 2007 |
2 |
| 12 |
17561096 | MAO-A-induced mitogenic signaling is mediated by reactive oxygen species, MMP-2, and the sphingolipid pathway. | 2007 Jul 1 |
4 |
| 13 |
17868200 | Amine oxidases and monooxygenases in the in vivo metabolism of xenobiotic amines in humans: has the involvement of amine oxidases been neglected? | 2007 Oct |
4 |
| 14 |
12765230 | Fatal combination of moclobemide overdose and whisky. | 2003 Mar |
1 |
| 15 |
12855685 | Decreased methylation and transcription repressor Sp3 up-regulated human monoamine oxidase (MAO) B expression during Caco-2 differentiation. | 2003 Sep 19 |
1 |
| 16 |
10498294 | Reactive oxygen species production by monoamine oxidases in intact cells. | 1999 May |
1 |
| 17 |
10571247 | High expression of monoamine oxidases in human white adipose tissue: evidence for their involvement in noradrenaline clearance. | 1999 Dec 1 |
1 |
| 18 |
10647887 | Association between monoamine oxidase A activity in human male skin fibroblasts and genotype of the MAOA promoter-associated variable number tandem repeat. | 1999 Dec |
1 |
| 19 |
9622553 | Selective inhibitors of monoamine oxidase (MAO). 5. 1-Substituted phenoxathiin inhibitors containing no nitrogen that inhibit MAO A by binding it to a hydrophobic site. | 1998 Jun 4 |
2 |
| 20 |
9663810 | Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man. | 1998 Jun |
1 |
| 21 |
9503566 | [Monoamine oxidase inhibitors and pressor response to dietary amines]. | 1997 Nov-Dec |
2 |
| 22 |
8695909 | The monoamine regulon including syntheses of arylsulfatase and monoamine oxidase in bacteria. | 1996 Jun |
2 |
| 23 |
8861736 | Tyramine pharmacodynamics during combined administration of lazabemide and moclobemide. | 1996 Apr |
2 |
| 24 |
8313394 | Preclinical and early clinical studies with BW 1370U87, a reversible competitive monoamine oxidase-A inhibitor. | 1993 |
1 |
| 25 |
8313396 | Drug interactions with reversible monoamine oxidase-A inhibitors. | 1993 |
1 |
| 26 |
8390270 | Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition. | 1993 |
2 |
| 27 |
1483487 | Influence of food on the tyramine pressor effect during chronic moclobemide treatment of healthy volunteers. | 1992 |
1 |
| 28 |
1546143 | Biochemistry and pharmacology of moclobemide, a prototype RIMA. | 1992 |
1 |
| 29 |
1609114 | The new generation of monoamine oxidase inhibitors. | 1992 |
1 |
| 30 |
1609337 | Recent advances in antidepressant drugs. | 1992 Jun 6 |
2 |
| 31 |
1741773 | Problems with the measurement of monoamine oxidase A protein concentration in mitochondrial preparations. Revised molecular activities and implications for estimating ratios of MAO A:MAO B molecules from radiochemical assay data. | 1991 Oct 24 |
1 |
| 32 |
1759390 | [The role of monoamine oxidase in the regulation of mitochondrial energy functions]. | 1991 Sep-Oct |
1 |
| 33 |
2248084 | Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors. | 1990 |
2 |
| 34 |
2587674 | [Hypertensive crises with reversible inhibitors of monoamine oxidases? Results of tyramine interaction studies]. | 1989 Aug |
1 |
| 35 |
2619973 | Biochemical aspects of the pharmacology of moclobemide. The implications of animal studies. | 1989 Oct |
2 |
| 36 |
2794993 | Tyramine potentiation during treatment with MAO inhibitors: brofaromine and moclobemide vs irreversible inhibitors. | 1989 |
1 |
| 37 |
22156310 | Potentiation of the pressor effect of oral and intravenous tyramine during administration of the selective MAO-A inhibitor moclobemide in healthy volunteers. | 1989 Jan |
1 |
| 38 |
3266532 | Design and early clinical evaluation of selective inhibitors of monoamine oxidase. | 1988 |
1 |
| 39 |
3480939 | Monoamine oxidase B inhibition and the "cheese effect". | 1987 |
1 |
| 40 |
3928010 | Modification of blood pressure and nictitating membrane response to sympathetic amines by selective monoamine oxidase inhibitors, types A and B, in the cat. | 1985 Jun |
1 |
| 41 |
3929314 | Tyramine pressor sensitivity changes during deprenyl treatment. | 1985 |
1 |
| 42 |
6791210 | Tyramine infusions and selective monoamine oxidase inhibitor treatment. II. Interrelationships among pressor sensitivity changes, platelet MAO inhibition, and plasma MHPG reduction. | 1981 |
1 |